Parallel Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Parallel Advisors's HALO Position: Q2 2026 in Review
Parallel Advisors increased its Halozyme (HALO) stake by 21% in Q2 2026, buying an estimated $29.5K and bringing the position to 2,460 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #1312.
Parallel Advisors first reported a position in HALO in Q2 2019 and has held it in 29 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Parallel Advisors held 2,460 shares of Halozyme worth $193K as of Q2 2026.
- Parallel Advisors bought 432 Halozyme shares in Q2 2026, an estimated $29.5K.
- Halozyme made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1312 holding.
- Parallel Advisors first reported a position in Halozyme in Q2 2019 and has held it in 29 quarters since.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.